CRL News and Press, Charles River Laboratories International Inc. From 10/11/23

Company selected as Energy Star Top Project of the Year for Energy Recovery System, and develops industry partnerships to align with sustainable initiatives Charles River Laboratories International, Inc. (NYSE: CRL) today announced that, while working toward previously announced environ...

2023-10-06 14:46:22 ET Summary Charles River Laboratories International, Inc. shares have fallen over 20% due to a tougher 2023 outlook and divestment of the avian vaccine business. The company's strong momentum during the pandemic led to shares peaking at $450, but they have sinc...

The platform can reduce lentiviral vector production timelines from 18 months to less than 7 months Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™ . The platform has the...

RightSource is Charles River’s purpose-built lab offering that provides accessible GMP quality control testing next to the manufacturing floor Charles River Laboratories International, Inc. (NYSE: CRL) today announced the opening of another RightSource SM facility, and fi...

2023-09-21 10:07:18 ET More on Charles River Seeking Alpha’s Quant Rating on Charles River Laboratories Historical earnings data for Charles River Laboratories Charles River Laboratories: Very Attractive After The Pullback Charles River inks deal with ...

2023-09-15 15:00:00 ET More on the markets Key Region Of Support Sides With SPY Bullish Case Market Crosswinds And Nasdaq Looking Better Than Dow The Fed's rate-hike cycle has 'most assuredly ended' -- Lawrence Fuller Fund managers finally embrace U.S. stocks...

2023-09-14 08:35:46 ET More on Charles River Seeking Alpha’s Quant Rating on Charles River Laboratories Historical earnings data for Charles River Laboratories Financial information for Charles River Laboratories Charles River Laboratories Internationa...

Logica, an offering from Charles River and Valo Health, will be used to discover first-in-class therapeutics against high value targets in the Related Sciences portfolio Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences (“RS”), a data science-...

NGS assay demonstrated a broader detection range than standard in vivo tests with comparable or higher analytical sensitivity Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest SAS, a leader in the development and provision of next-generation sequencing (NGS) test...

2023-08-29 00:42:16 ET Summary Ariel Investments' 13F portfolio value increased by 2% to $10.56B in Q2 2023. The portfolio is diversified with around 150 positions, with the largest stakes in Baidu, Mattel, Philip Morris, Kennametal, and Generac Holdings. The Ariel Fund has a ...